PAB huge announcement: New United States patent granted for Patrys' deoxymab assets
Further United States patent granted for PAB deoxymab assets
A patent covering the use of PAB novel deoxymabs (including both PAT-DX1 and PAT-DX3) in combination with radiosensitising agent(s) that damage DNA or inhibit DNA repair
- Forums
- ASX - Day Trading
- Morning trading March 31
Morning trading March 31, page-2
-
- There are more pages in this discussion • 343 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)